Showing results (451-460 of 1,020) with videos related to
Sort By:
Pageof 102
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 17, 2025
[Access to and Transitions within the Medical Care Process of Persons with Down Syndrome and Dementia: A Qualitative Analysis]Anke Walendzik, Milena Weitzel, Godwin D Giebel, et al.Fortschritte Der Neurologie-Psychiatrie|November 5, 2025
[A review and guideline for the adequate and interdisciplinary (socio-)medical care of people with Down syndrome and dementia development]Olivia Wagemann, Valentina A Tesky, Arthur Schall, et al.Cardiovascular Research|June 29, 2026
Proteomic signatures as biomarkers of atherosclerosis burdenLanyue Zhang, Murad Omarov, LingLing Xu, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2018
Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsAndré Strydom, Antonia Coppus, Rafael Blesa, et al.Research Square|June 30, 2025
Proteomic Signatures as Biomarkers of Atherosclerosis BurdenLanyue Zhang, Murad Omarov, LingLing Xu, et al.Cerebral Circulation - Cognition and Behavior|April 15, 2025
The relation between cerebral small vessel function and white matter microstructure in monogenic and sporadic small vessel disease - the ZOOM@SVDs studyNaomi Vlegels, Hilde van den Brink, Anna Kopczak, et al.Journal of Extracellular Vesicles|December 2, 2021
Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patientsLisa Rausch, Konstantin Lutz, Martina Schifferer, et al.Developmental Cell|July 14, 2015
Actin filament turnover drives leading edge growth during myelin sheath formation in the central nervous systemSchanila Nawaz, Paula Sánchez, Sebastian Schmitt, et al.Science Translational Medicine|August 30, 2019
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's diseaseMichael Ewers, Nicolai Franzmeier, Marc Suárez-Calvet, et al.Annals of Neurology|March 27, 2022
Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181Patrick Oeckl, Olivia Wagemann, Steffen Halbgebauer, et al.Pageof 102